Small anticancer drug release by light
Aiming to engineer simple, neutral, strongly amphiphilic photoactive nanoparticles (NPs) to specifically target cancer cell lysosomes for drug transport and
Category: Drug delivery
Cyclodextrin Metal-Organic Framework as a Broad-Spectrum Potential Delivery Vehicle for the Gasotransmitters
The important role of gasotransmitters in physiology and pathophysiology suggest employing gasotransmitters for biomedical treatment. Unfortunately, the difficulty in storage
Published compilation of the list of approved cyclodextrin-containing drug products
A group of researchers at CycloLab continuously follow the new drug composition approvals especially those benefiting the use of cyclodextrins.
New US patent for SBECD purification by CycloLab
The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was
Symposium of Drug Delivery Systems
The 10th Annual International Symposium of Drug Delivery Systems (SDDS-2023) postponed from the last year is going to be held
Sustainable γ-cyclodextrin frameworks containing ultra-fine silver nanoparticles with enhanced antimicrobial efficacy
Cyclodextrin metal-organic frameworks (CD-MOF) are a class of biocompatible MOFs with a great potential in drug delivery applications. Original CD-MOF
Transdermal delivery by smart tattoo
Tattoos are already used in the clinic to mark where doctors will apply radiation treatments, to correct skin discoloration, to mark
Cyclodextrin based dermatological formulations Dermatopharmaceutical and cosmetic application
The incorporation of CDs in dermopharmaceutical and cosmetics formulations has received much attention since the late 1970 s by enhancing
Inclusion complexes of the steroid hormones 17β-estradiol and progesterone with β- and γ-cyclodextrin hosts
This study addresses the poor solubility of two potent steroid hormones, 17β-estradiol (BES) and progesterone (PRO), via their complexation with
Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD
Remdesivir has emerged as a promising antiviral drug against SARS-CoV-2. However, data regarding the clinical benefits of remdesivir in patients